![AbbVie Canada on Twitter: "#FridayFact: 1 in 4 adults living with #diabetes are undiagnosed. Without treatment or sufficient support, people with diabetes are at risk of serious and life-threatening complications. https://t.co/4dMKNneH3v" / AbbVie Canada on Twitter: "#FridayFact: 1 in 4 adults living with #diabetes are undiagnosed. Without treatment or sufficient support, people with diabetes are at risk of serious and life-threatening complications. https://t.co/4dMKNneH3v" /](https://pbs.twimg.com/media/FGQylOgWYAg4MAZ.jpg:large)
AbbVie Canada on Twitter: "#FridayFact: 1 in 4 adults living with #diabetes are undiagnosed. Without treatment or sufficient support, people with diabetes are at risk of serious and life-threatening complications. https://t.co/4dMKNneH3v" /
![Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top | Fierce Pharma Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/2016-08/Diabetes%20drugs%20and%20devices.jpg?VersionId=.Wigt0QE9TlqcVzjG3U4o6bymO4BgkBP)
Diabetes drugs pop on January's TV ad spending list, but AbbVie's Humira stays at the top | Fierce Pharma
AbbVie - On #WorldDiabetesDay, we're partnering with International Diabetes Federation to highlight the importance of early diagnosis and monitoring in preventing #vision complications related to #diabetes. Join the #IfNotNowWhen pledge to support
![Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts | Fierce Pharma Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1643901740/Lilly.jpg/Lilly.jpg?VersionId=abXbx5ppKDn9hcCtUcSd9kUDb1KY7etj)
Eli Lilly, AbbVie positioned for long-term growth, while Bristol Myers Squibb may struggle: analysts | Fierce Pharma
![Novo Nordisk's Ozempic spends big on TV in August but still trails AbbVie, Pfizer big guns | Fierce Pharma Novo Nordisk's Ozempic spends big on TV in August but still trails AbbVie, Pfizer big guns | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1536023513/watching-tv.png/watching-tv.png?VersionId=bKViA8VmUMBY4n0bCxczEbcIh7wx0PZY)